Seattle Genetics

Seattle Genetics, on the Verge of Going Commercial, Seeks to Keep Its Scientific Soul
Motley Fool
Tue, 07/5/11 - 11:29 am
Seattle Genetics
July Catalysts for Biotech and Drug Stocks
Minyanville
Tue, 07/5/11 - 09:58 am
Seattle Genetics
Bristol-Myers Squibb
JNJ
advisory panels
FDA
Transcept
AstraZeneca
GSK
Human Genome Sciences
Merck
Theravance
Amgen
Biogen Idec
Acorda Therapeutics
[video] The Next Big Thing In Biotech: Seattle Genetics
TheStreet.com
Fri, 07/1/11 - 09:57 am
Seattle Genetics
6 Healthcare Companies With July Catalysts
Seeking Alpha
Thu, 06/30/11 - 07:26 pm
Alexa
AstraZeneca
Bristol-Myers Squibb
JNJ
Seattle Genetics
Transcept
FDA committee to review Seattle Genetics cancer drug applications in July
bizjournals.com
Thu, 06/16/11 - 10:19 pm
FDA
Seattle Genetics
brentuximab vedotin
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS (Brentuximab Vedotin) in Systemic ALCL at EHA Annual Meeting
Enhanced Online News
Sat, 06/11/11 - 10:58 am
systemic anaplastic large cell lymphoma
Seattle Genetics
Millennium
Adcetris
Seattle Genetics and Astellas start development of second experimental cancer drug
Yahoo/AP
Thu, 06/9/11 - 08:02 am
Seattle Genetics
Astellas
cancer
The Biggest Gift Biotechs Can Give to Investors
Motley Fool
Tue, 05/31/11 - 12:36 pm
investors
biotech
Vertex Pharmaceuticals
Exelixis
CytRx
GSK
Novavax
JNJ
Pfizer
Biogen Idec
Seattle Genetics
Immunogen
Alnylam
Millennium and Seattle Genetics Announce Brentuximab Vedotin (SGN-35) Presentations at 16th Congress of the European Hematology Association
Yahoo/BusinessWire
Sat, 05/28/11 - 11:56 am
Millennium
Seattle Genetics
brentuximab vedotin
SGN-35
Hodgkin's lymphoma
Seattle Genetics says FDA will make two rulings on its cancer drug brentuximab by Aug. 30
Yahoo/AP
Mon, 05/2/11 - 12:39 pm
FDA
brentuximab vedotin
Seattle Genetics
Hodgkin's lymphoma
Insider Picks: 5 Biotech Stocks Being Snapped Up by Insider Executives
Seeking Alpha
Wed, 04/27/11 - 11:46 am
Complete Genomics
Corcept Therapeutics
Seattle Genetics
Ziopharm
MannKind
Seattle Genetics and Genmab expand collaboration
Yahoo/AP
Tue, 04/19/11 - 11:08 am
Seattle Genetics
Genmab
cancer
10 promising late-stage cancer drugs
Fierce Biotech
Tue, 04/5/11 - 10:47 pm
cancer
Carfilzomib
crizotinib
vismodegib
Oncovex
PLX4032
Ponatinib
SGN-35
tivozanib
T-DM1
cabozantinib
ONYX Pharmaceuticals
Pfizer
Genentech
Curis
Amgen
Plexxikon
Seattle Genetics
Ariad Pharmaceuticals
Aveo Pharmaceutical
Exelixis
Roche
Seattle Genetics shares rise in heavy trading
Bizjournals.com
Tue, 04/5/11 - 09:55 pm
Seattle Genetics
antibody-drug conjugate
Better Buy? Seattle Genetics or ImmunoGen
Motley Fool
Thu, 03/31/11 - 06:59 pm
Immunogen
Seattle Genetics
Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with Abbott
Yahoo
Tue, 03/22/11 - 10:05 am
Abbott Laboratories
antibody-drug conjugate
Seattle Genetics
Millennium expands cancer pact with red-hot Seattle Genetics
Fierce Biotech
Tue, 03/15/11 - 12:27 pm
Millennium
Seattle Genetics
antibody-drug conjugate
3 Oversold Biotech Stocks Being Snapped up By Insiders
Seeking Alpha
Fri, 03/11/11 - 01:29 pm
MannKind
Seattle Genetics
Theravance
Battered but Unbroken Biotechs
Seeking Alpha
Tue, 03/1/11 - 10:26 am
Amylin
Alnylam
Celldex
Exelixis
Human Genome Sciences
Isis Pharmaceuticals
Lexicon Pharmaceuticals
Neurocrine
Nektar
ONYX Pharmaceuticals
Ziopharm
Seattle Genetics
Top Biotech Takeout Targets in 2011
Minyanville
Fri, 02/18/11 - 03:32 pm
M&A
biotech
Biogen Idec
Human Genome
Seattle Genetics
GSK
Dendreon
Actelion
Biomarin
Exelixis
Vertex Pharmaceuticals
Celgene
Alexion
Shire
InterMune
Lexicon Pharmaceuticals
Savient
Merck KGaA

Pages